Literature DB >> 7647337

Difference in thymidylate synthetase activity in involved nodes compared with primary tumor in breast cancer patients.

K Komaki1, Y Kamamura, Y Ohmine, M Sasa, K Tanaka, H Inoue, T Uyama, T Morimoto, Y Monden.   

Abstract

Thymidylate synthetase (TS) is a key enzyme as a methyl donor in the methylation reaction from dUMP to dTMP. TS activity was assessed in various tissue of mammary disorders. The descending order of TS activity was as follows: cancer-positive nodes, primary cancers, cancer-negative nodes, benign lesions, and normal parenchyma. Significant differences in TS activity were found between the positive nodes and each of the other tissues (p < 0.01). In node-positive cases, a significant correlation in TS activity was found between the primary cancers and positive nodes (r = 0.616, p = 0.033). There was no correlation between the nodal status and the TS activity in primary cancers. In 11 of 12 cases, the TS activity of positive nodes was higher than the 'calculated' TS activity of the primary cancer, which was defined as the TS activity per unit weight of cancer cells. A significant correlation was found between the calculated TS activity and the mitotic frequency in primary cancers (r = 0.697, p = 0.0001). On the other hand, a significant correlation could not be found between the TS activity and the mitotic frequency in positive nodes (r = 0.364, p = 0.244).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7647337     DOI: 10.1007/bf00668205

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  9 in total

Review 1.  Enzymology of cancer cells (first of two parts).

Authors:  G Weber
Journal:  N Engl J Med       Date:  1977-03-03       Impact factor: 91.245

2.  In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas.

Authors:  C P Spears; A H Shahinian; R G Moran; C Heidelberger; T H Corbett
Journal:  Cancer Res       Date:  1982-02       Impact factor: 12.701

Review 3.  Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture.

Authors:  G Weber
Journal:  Cancer Res       Date:  1983-08       Impact factor: 12.701

4.  Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase.

Authors:  E Chu; D M Koeller; J L Casey; J C Drake; B A Chabner; P C Elwood; S Zinn; C J Allegra
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

5.  Activities of various enzymes of pyrimidine nucleotide and DNA syntheses in normal and neoplastic human tissues.

Authors:  Y Maehara; H Nakamura; Y Nakane; K Kawai; M Okamoto; S Nagayama; T Shirasaka; S Fujii
Journal:  Gan       Date:  1982-04

6.  Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil.

Authors:  C P Spears; B G Gustavsson; M S Mitchell; D Spicer; M Berne; L Bernstein; P V Danenberg
Journal:  Cancer Res       Date:  1984-09       Impact factor: 12.701

7.  5-Fluorouracil and UFT-sensitive gastric carcinoma has a high level of thymidylate synthase.

Authors:  Y Maehara; T Kusumoto; H Kusumoto; H Anai; Y Sakaguchi; Y Kido; T Okamura; D Korenaga; K Sugimachi
Journal:  Cancer       Date:  1989-05-01       Impact factor: 6.860

8.  Thymidylate synthetase activity and fluorouracil sensitivity of human colonic cancer and normal mucosal tissue preparations.

Authors:  W H Wolberg; J Morin
Journal:  Cancer       Date:  1981-03-15       Impact factor: 6.860

9.  Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.

Authors:  H J BLOOM; W W RICHARDSON
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.